Clinical trial
A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05850689 is registered in ClinicalTrials.gov with Intra-Cellular Therapies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Lead sponsor
- Intra-Cellular Therapies, Inc.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- May 2, 2023
- Completion date
- April 5, 2027
- Enrollment
- 470 (estimated)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.